Newborn blood spots may reveal hidden risks from common virus

NCT ID NCT07635368

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study analyzes dried blood spots from 630 newborns to find protein and RNA markers that could predict which babies with congenital CMV will develop hearing loss or other problems. Researchers will compare samples from infected babies who had complications, those who did not, and healthy controls. The goal is to improve understanding of the disease and potentially develop a screening test.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could lead to a simple blood test at birth to identify which babies with congenital CMV are at risk for hearing loss or other problems.
What could go wrong
This is an observational study, not a treatment trial. It may not find reliable markers, and any future test would need years of additional validation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CONGENITAL CYTOMEGALOVIRUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Department of Congenital Disorders, Statens Serum Institut

    RECRUITING

    Copenhagen, 2300, Denmark

  • Department of Paediatrics and Adolescent Medicine, Rigshospitalet

    RECRUITING

    Copenhagen, 2100, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.